You Position: Home > Paper

A comparision between β-AP and INS in the patient with Alzheimer disease by different treatment methods

( views:211, downloads:0 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
Issue:
11
DOI:
10.3760/cma.j.issn.1008-6706.2005.11.005
Key Word:
阿尔茨海默病;淀粉样β蛋白;胰岛素

Abstract: 目的测定阿尔茨海默病(AD)患者治疗前后β-淀粉样蛋白(β-AP)和胰岛素(INS)含量变化,进而比较不同药物治疗效果.方法用放免法测定60例患者和30例正常对照组的β-AP和INS含量,并按不同药物治疗前后分组.结果轻度痴呆认知功能、日常生活能力,躯体并发症发生率与中度、重度痴呆比较差异有显著意义(P<0.05);AD组血清β-AP含量均明显高于正常对照组(P<0.01),治疗后含量均低于治疗前(P<0.05~0.01);4~8个月脑活素组β-AP的含量明显高于脑复康组(P<0.05~0.01);老年性痴呆胰岛素含量明显低于血管性痴呆组和正常对照组(P<0.05);脑活素治疗AD病疗效高于脑复康.结论阿尔茨海默病患者治疗前后测定β-AP和INS含量变化,对病情的预测和疗效的评定有一定的帮助.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn